Medical Sciences Correction for “A hypothalamic pathway for Augmentor α-controlled body weight regulation,” by Mansoor Ahmed, Navjot Kaur, Qianni Cheng, Marya Shanabrough, Evgenii O. Tretiakov, Tibor Harkany, Tamas L. Horvath, and Joseph Schlessinger, which published April 11, 2022; 10.1073/pnas.2200476119 (Proc. Natl. Acad. Sci. U.S.A. 119, e2200476119).
The authors note that “Author Joseph Schlessinger is a member of the Scientific Advisory Board of Celldex Therapeutics, which holds a patent for ‘Regulators of Anaplastic Lymphoma Kinase and Uses Thereof.’” Although this patent and their PNAS article address different questions, the authors are sensitive to any perceptions of competing interest, and thus wish to be transparent about Dr. Schlessinger’s association with Celldex. The competing interest statement has been updated.